Cargando…
Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis
CONTEXT: Dercum’s disease (DD) and Roch-Leri mesosomatic lipomatosis (LMS) are rare and poorly characterized diseases. The clinical presentation combines multiple lipomas, painful in DD in contrast with LMS, without lipoatrophy. OBJECTIVE: To identify any specific metabolic and immune phenotype of D...
Autores principales: | , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243498/ https://www.ncbi.nlm.nih.gov/pubmed/34187516 http://dx.doi.org/10.1186/s13023-021-01920-3 |
_version_ | 1783715762516525056 |
---|---|
author | Lemaitre, Madleen Chevalier, Benjamin Jannin, Arnaud Le Mapihan, Kristell Boury, Samuel Lion, Georges Labalette, Myriam Vantyghem, Marie-Christine |
author_facet | Lemaitre, Madleen Chevalier, Benjamin Jannin, Arnaud Le Mapihan, Kristell Boury, Samuel Lion, Georges Labalette, Myriam Vantyghem, Marie-Christine |
author_sort | Lemaitre, Madleen |
collection | PubMed |
description | CONTEXT: Dercum’s disease (DD) and Roch-Leri mesosomatic lipomatosis (LMS) are rare and poorly characterized diseases. The clinical presentation combines multiple lipomas, painful in DD in contrast with LMS, without lipoatrophy. OBJECTIVE: To identify any specific metabolic and immune phenotype of DD and LMS. DESIGN AND PATIENTS: This monocentric retrospective study included 46 patients: 9 DD, 11 LMS, 18 lean and 8 obese controls. Metabolic and immunohematological characteristics of each group were compared. RESULTS: The median age of the patients was similar in the 3 groups (31 years). The number of women, and of basophils, and CD3(+), CD4(+) and CD8(+) T lymphocytes was significantly higher in the DD versus the LMS group, without any difference of the metabolic parameters. Weight, BMI, blood pressure, gamma-GT, leptin, fasting insulin and C-peptide levels, fat mass percentage, and intra/total abdominal fat ratio were significantly higher in each lipomatosis group compared with the lean group. Compared with the lean group, the DD group had significantly higher fasting blood glucose, LDL-cholesterol, platelets, leukocytes, basophils, and a lower NK cell count, whereas the LMS group had a significantly lower rate of CD3, CD4, and CD8 lymphocytes. Compared with the obese controls, basophils remained higher in DD and T lymphocytes subpopulations lower in LMS groups. CONCLUSION: DD and LMS show a common background of obesity and metabolic phenotype, but a distinct immunohematological profile characterized by a higher number of basophils in DD patients, an inflammatory profile that could contribute to pain. T lymphocyte depletion was present in LMS. These findings could offer specific therapeutic opportunities, especially for painful DD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01920-3. |
format | Online Article Text |
id | pubmed-8243498 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-82434982021-06-30 Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis Lemaitre, Madleen Chevalier, Benjamin Jannin, Arnaud Le Mapihan, Kristell Boury, Samuel Lion, Georges Labalette, Myriam Vantyghem, Marie-Christine Orphanet J Rare Dis Research CONTEXT: Dercum’s disease (DD) and Roch-Leri mesosomatic lipomatosis (LMS) are rare and poorly characterized diseases. The clinical presentation combines multiple lipomas, painful in DD in contrast with LMS, without lipoatrophy. OBJECTIVE: To identify any specific metabolic and immune phenotype of DD and LMS. DESIGN AND PATIENTS: This monocentric retrospective study included 46 patients: 9 DD, 11 LMS, 18 lean and 8 obese controls. Metabolic and immunohematological characteristics of each group were compared. RESULTS: The median age of the patients was similar in the 3 groups (31 years). The number of women, and of basophils, and CD3(+), CD4(+) and CD8(+) T lymphocytes was significantly higher in the DD versus the LMS group, without any difference of the metabolic parameters. Weight, BMI, blood pressure, gamma-GT, leptin, fasting insulin and C-peptide levels, fat mass percentage, and intra/total abdominal fat ratio were significantly higher in each lipomatosis group compared with the lean group. Compared with the lean group, the DD group had significantly higher fasting blood glucose, LDL-cholesterol, platelets, leukocytes, basophils, and a lower NK cell count, whereas the LMS group had a significantly lower rate of CD3, CD4, and CD8 lymphocytes. Compared with the obese controls, basophils remained higher in DD and T lymphocytes subpopulations lower in LMS groups. CONCLUSION: DD and LMS show a common background of obesity and metabolic phenotype, but a distinct immunohematological profile characterized by a higher number of basophils in DD patients, an inflammatory profile that could contribute to pain. T lymphocyte depletion was present in LMS. These findings could offer specific therapeutic opportunities, especially for painful DD. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1186/s13023-021-01920-3. BioMed Central 2021-06-29 /pmc/articles/PMC8243498/ /pubmed/34187516 http://dx.doi.org/10.1186/s13023-021-01920-3 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data. |
spellingShingle | Research Lemaitre, Madleen Chevalier, Benjamin Jannin, Arnaud Le Mapihan, Kristell Boury, Samuel Lion, Georges Labalette, Myriam Vantyghem, Marie-Christine Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis |
title | Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis |
title_full | Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis |
title_fullStr | Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis |
title_full_unstemmed | Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis |
title_short | Metabolic and immunological phenotype of rare lipomatoses: Dercum’s disease and Roch-Leri mesosomatic lipomatosis |
title_sort | metabolic and immunological phenotype of rare lipomatoses: dercum’s disease and roch-leri mesosomatic lipomatosis |
topic | Research |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8243498/ https://www.ncbi.nlm.nih.gov/pubmed/34187516 http://dx.doi.org/10.1186/s13023-021-01920-3 |
work_keys_str_mv | AT lemaitremadleen metabolicandimmunologicalphenotypeofrarelipomatosesdercumsdiseaseandrochlerimesosomaticlipomatosis AT chevalierbenjamin metabolicandimmunologicalphenotypeofrarelipomatosesdercumsdiseaseandrochlerimesosomaticlipomatosis AT janninarnaud metabolicandimmunologicalphenotypeofrarelipomatosesdercumsdiseaseandrochlerimesosomaticlipomatosis AT lemapihankristell metabolicandimmunologicalphenotypeofrarelipomatosesdercumsdiseaseandrochlerimesosomaticlipomatosis AT bourysamuel metabolicandimmunologicalphenotypeofrarelipomatosesdercumsdiseaseandrochlerimesosomaticlipomatosis AT liongeorges metabolicandimmunologicalphenotypeofrarelipomatosesdercumsdiseaseandrochlerimesosomaticlipomatosis AT labalettemyriam metabolicandimmunologicalphenotypeofrarelipomatosesdercumsdiseaseandrochlerimesosomaticlipomatosis AT vantyghemmariechristine metabolicandimmunologicalphenotypeofrarelipomatosesdercumsdiseaseandrochlerimesosomaticlipomatosis |